These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28286503)

  • 21. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures.
    Vezzani A; Maroso M; Balosso S; Sanchez MA; Bartfai T
    Brain Behav Immun; 2011 Oct; 25(7):1281-9. PubMed ID: 21473909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C Virus NS3 Mediated Microglial Inflammation via TLR2/TLR6 MyD88/NF-κB Pathway and Toll Like Receptor Ligand Treatment Furnished Immune Tolerance.
    Rajalakshmy AR; Malathi J; Madhavan HN
    PLoS One; 2015; 10(5):e0125419. PubMed ID: 25965265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Toll-like receptor/MYD88 signaling in neurodegenerative diseases.
    Xiang W; Chao ZY; Feng DY
    Rev Neurosci; 2015; 26(4):407-14. PubMed ID: 25870959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.
    Harris SA; Harris EA
    J Alzheimers Dis; 2015; 48(2):319-53. PubMed ID: 26401998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The brain as a target for inflammatory processes and neuroprotective strategies.
    Skaper SD
    Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross Talk between Inhibitory Immunoreceptor Tyrosine-Based Activation Motif-Signaling and Toll-Like Receptor Pathways in Macrophages and Dendritic Cells.
    Hirsch I; Janovec V; Stranska R; Bendriss-Vermare N
    Front Immunol; 2017; 8():394. PubMed ID: 28439271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease.
    Minter MR; Taylor JM; Crack PJ
    J Neurochem; 2016 Feb; 136(3):457-74. PubMed ID: 26509334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches.
    Van Eldik LJ; Thompson WL; Ralay Ranaivo H; Behanna HA; Martin Watterson D
    Int Rev Neurobiol; 2007; 82():277-96. PubMed ID: 17678967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
    Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
    J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis.
    Orsini F; De Blasio D; Zangari R; Zanier ER; De Simoni MG
    Front Cell Neurosci; 2014; 8():380. PubMed ID: 25426028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptors and their role in gastrointestinal disease.
    Testro AG; Visvanathan K
    J Gastroenterol Hepatol; 2009 Jun; 24(6):943-54. PubMed ID: 19638078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of neuroimmunomodulation in Alzheimer's disease.
    Maccioni RB; Rojo LE; Fernández JA; Kuljis RO
    Ann N Y Acad Sci; 2009 Feb; 1153():240-6. PubMed ID: 19236346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of complement in neurodegeneration and neuroinflammation.
    Bonifati DM; Kishore U
    Mol Immunol; 2007 Feb; 44(5):999-1010. PubMed ID: 16698083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wnt signaling in the nervous system and in Alzheimer's disease.
    Inestrosa NC; Varela-Nallar L
    J Mol Cell Biol; 2014 Feb; 6(1):64-74. PubMed ID: 24549157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
    Calabrese V; Boyd-Kimball D; Scapagnini G; Butterfield DA
    In Vivo; 2004; 18(3):245-67. PubMed ID: 15341181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paliperidone prevents brain toll-like receptor 4 pathway activation and neuroinflammation in rat models of acute and chronic restraint stress.
    MacDowell KS; Caso JR; Martín-Hernández D; Madrigal JL; Leza JC; García-Bueno B
    Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of toll-like receptor signalling in Abeta uptake and clearance.
    Tahara K; Kim HD; Jin JJ; Maxwell JA; Li L; Fukuchi K
    Brain; 2006 Nov; 129(Pt 11):3006-19. PubMed ID: 16984903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Enemy within: Innate Surveillance-Mediated Cell Death, the Common Mechanism of Neurodegenerative Disease.
    Richards RI; Robertson SA; O'Keefe LV; Fornarino D; Scott A; Lardelli M; Baune BT
    Front Neurosci; 2016; 10():193. PubMed ID: 27242399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate immune activation: Parallels in alcohol use disorder and Alzheimer's disease.
    Ramos A; Joshi RS; Szabo G
    Front Mol Neurosci; 2022; 15():910298. PubMed ID: 36157070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammation and Wnt Signaling: Target for Immunomodulatory Therapy?
    Jridi I; Canté-Barrett K; Pike-Overzet K; Staal FJT
    Front Cell Dev Biol; 2020; 8():615131. PubMed ID: 33614624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.